Emerald Mutual Fund Advisers Trust’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
AA
Emerald Mutual Fund Advisers Trust's CDLX Position: Q1 2020 in Review
Emerald Mutual Fund Advisers Trust sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 1,198 shares — an estimated $753K sold.
Emerald Mutual Fund Advisers Trust first reported a position in CDLX in Q1 2018 and held it in 4 quarters. The position peaked at $6.92M in Q3 2018. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.
- Emerald Mutual Fund Advisers Trust reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
- Emerald Mutual Fund Advisers Trust sold 1,198 Cardlytics shares in Q1 2020, an estimated $753K.
- Emerald Mutual Fund Advisers Trust first reported a position in Cardlytics in Q1 2018 and held it in 4 quarters.
- Emerald Mutual Fund Advisers Trust's Cardlytics position peaked at $6.92M in Q3 2018.
- 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2020, filed 30 Apr 2020.